Binding of detergents and inhibitors to bovine complex I - a novel purification procedure for bovine complex I retaining full inhibitor sensitivity  by Okun, Jürgen G. et al.
Binding of detergents and inhibitors to bovine complex I - a novel
puri¢cation procedure for bovine complex I retaining full inhibitor
sensitivity
Ju«rgen G. Okun, Volker Zickermann, Klaus Zwicker, Hermann Scha«gger,
Ulrich Brandt *
Universita«tsklinikum Frankfurt, Institut fu«r Biochemie I, Zentrum der Biologischen Chemie, Theodor-Stern-Kai 7, Haus 25B,
D-60590 Frankfurt am Main, Germany
Received 23 December 1999; received in revised form 7 March 2000; accepted 15 March 2000
Abstract
Mitochondrial complex I exhibits some peculiar and poorly understood features regarding the effects of detergents on
activity and sensitivity to hydrophobic inhibitors that are not seen with other membrane complexes using ubiquinone as a
substrate. Therefore, we investigated the interaction of complex I from bovine heart mitochondria with different types of
detergents by monitoring activity, degree of inhibition and inhibitor binding in the presence of increasing concentrations of
detergent. It is shown that apart from their nature as solubilizing and delipidating agents the polyoxyethylene-ether
detergents Triton X-100, Brij-35 and Thesit act as specific inhibitors of complex I and compete with classical complex I
inhibitors for a common binding domain. These findings were used to develop a novel large-scale chromatographic
procedure for isolation of inhibitor-sensitive NADH:ubiquinone oxidoreductase (complex I) from bovine heart
mitochondria. The enzyme was purified by selective solubilization in Triton X-100 and subsequent hydroxylapatite, ion-
exchange and gel-exclusion chromatography. By switching detergents from Triton X-100 to dodecylmaltoside after
hydroxylapatite chromatography the procedure yields highly pure, monodisperse and fully inhibitor-sensitive
enzyme. ß 2000 Elsevier Science B.V. All rights reserved.
1. Introduction
The proton-pumping NADH:ubiquinone oxidore-
ductase (EC 1.6.99.3, complex I) is the ¢rst mem-
brane-bound electron transport complex of the mito-
chondrial respiratory chain and accounts for 40% of
the proton translocating capacity across the inner
mitochondrial membrane. In mammals, it consists
of 43 subunits with a molecular mass of about 944
kDa [1].
A prerequisite for functional analysis of complex I
is a preparation which retains the enzyme in its na-
tive state. For crystallization of this large membrane
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Abbreviations: CC44, N-methyl-N-(3,4-dimethoxybenzyl)-4-
(p-tert-butylphenoxy)benzamide; Chaps, 3-[(3-cholamidopropyl)
dimethylammonio]-1-propane-sulfonate; CMC, critical micelle
concentration; DQA, 2-decyl-4-quinazolinyl-amine; EGTA, eth-
ylene glycol-bis(L-aminoethylether) N,N,NP,NP-tetraacetic acid;
FeS, iron^sulfur cluster; HAR, hexamineruthenium(III)-chloride;
NBQ, n-nonylubiquinone; NFQA, (6-methoxy-1,2,3,4-tetrahy-
dronaphth-2-yl)-(8-£uoroquinazolin-4-yl)amine; SDS^PAGE, so-
dium dodecyl sulfate^polyacrylamide gel electrophoresis; SMP,
submitochondrial particles; Tris, tris-(hydroxymethyl) amino-
methane
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protein complex, the isolated enzyme should not only
be native and highly pure, but also in a monodis-
perse and homogeneous state and have a low lipid
content [2]. However, one of the commonly observed
features of complex I is its susceptibility to solubili-
zation during various puri¢cation procedures as
monitored by inhibitor insensitivity and loss of cata-
lytic activity. The standard procedure to purify com-
plex I from bovine heart mitochondria by Hate¢ and
Rieske [3] retains inhibitor sensitivity, but uses chol-
ate as a detergent that is not monodisperse and
therefore not suited for crystallization experiments
[4]. This preparation also has a rather high lipid con-
tent and contains signi¢cant amounts of transhydro-
genase and bc1 complex as contaminants [3,4]. On
the other hand the excellent monodisperse prepara-
tion of Finel et al. [4] has irreversibly lost much of its
activity and is inhibitor insensitive. A similar prepa-
ration from the same laboratory by Buchanan and
Walker was reported to be inhibitor sensitive, but no
information on the amount of rotenone needed and
the incubation times was given [2]. The situation is in
stark contrast to the cytochrome bc1 complex which
requires exhaustive delipidation for inactivation leav-
ing only a few molecules of cardiolipin bound to the
complex; this inactivation is still fully reversible [5]
and has little e¡ect on inhibitor binding [6]. This
remarkable di¡erence between the two enzyme com-
plexes highlights the need to understand the e¡ect of
detergents especially on inhibitor binding to complex
I.
Using £uorescence quench titration and radioli-
gand binding assays [7] we could recently demon-
strate that complex I has only one extended inhibitor
binding domain with overlapping binding sites for all
its classical hydrophobic inhibitors.
Here we analyze the in£uence of various detergents
on activity and inhibitor binding. We demonstrate by
a simple kinetic model that polyoxyethylene-ether
detergents act as inhibitors and compete for the
same binding domain in complex I as other hydro-
phobic inhibitors.
Based on these results we have developed a novel
isolation procedure for bovine complex I which
yields the enzyme in a pure, homogeneous, monodis-
perse and fully inhibitor-sensitive state.
2. Materials and methods
2.1. Chemicals
The £uorescent complex I inhibitor NFQA (6-
methoxy-1,2,3,4-tetrahydronaphth-2-yl)(8-£uoroqui-
nazolin-4-yl)amine; AE C631392) was a kind gift
from Hoechst Schering AgrEvo Chemical GmbH
(Frankfurt am Main). n-Nonylubiquinone (NBQ)
was prepared essentially following the protocol of
Wan et al. [8]. Hydroxylapatite was prepared accord-
ing to [9] as modi¢ed by Scha«gger [10]. CC44, N-
methyl-N-(3,4-dimethoxybenzyl)-4-(p-tert-butylphe-
noxy)benzamide [11] was a kind gift from H.
Miyoshi, Kyoto University.
Peroxide-free Triton X-100 was purchased from
Serva (Heidelberg) and dodecylmaltoside was ob-
tained from Biomol Feinchemikalien GmbH (Ham-
burg). All other chemicals were purchased from Sig-
ma Aldrich Chemie GmbH (Deisenhofen) or Carl
Roth GmbH and Co. (Karlsruhe) in analytical qual-
ity.
2.2. Analytical methods
Protein was determined according to a modi¢ed
Lowry protocol [12]. Redox spectra of cytochromes
were recorded on a Shimadzu UV-300 spectropho-
tometer using the extinction coe⁄cients reported in
[13].
Low temperature EPR spectra were obtained on a
Bruker ESP 300E spectrometer equipped with a liq-
uid helium continuous £ow cryostat, ESR 900 from
Oxford Instruments. The samples were mixed with
NADH in the EPR tube and frozen in liquid nitro-
gen after 30 s reaction time.
The phospholipid content was determined as or-
ganic phosphate content following the protocol of
Chen et al. [14].
Acid extraction of £avin was performed essentially
as described by Koziol [15] and measured £uoromet-
rically by adding an internal standard of FMN (ex-
citation wavelength 455 nm, emission wavelength
530 nm). In the tested range of 0.1^1 WM the relation
between concentration and £uorescence intensity
(counts per second) was linear. Data were analyzed
by using the Psiplot software package version 4.61
(Poly Software International).
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Determination of ubiquinone content was per-
formed according to Kro«ger and Klingenberg [16]
using the ‘rapid extraction method’. About 10 mg
of isolated complex I were used for extraction. Tri-
cine SDS^PAGE was performed according to Scha«g-
ger and von Jagow [17].
2.3. Determination of catalytic activity
NADH:NBQ activity was measured using a Shi-
madzu UV-300 spectrophotometer in the dual wave-
length mode by following NADH oxidation at 340^
400 nm (O= 6.10 mM31 cm31) at 30‡C [7]. 100 WM
NADH and 50 Wg of bovine submitochondrial par-
ticles (SMP) or fractions from di¡erent preparation
steps or puri¢ed complex I were added to bu¡er
containing 50 mM Tris/HCl, pH 7.4, 5 WM Kresox-
im-Methyl Brio (to inhibit cytochrome bc1 complex)
and 2 mM KCN (to inhibit cytochrome c oxidase).
The catalytic reaction was started by addition of
60 WM NBQ. SMP were prepared essentially as de-
scribed in [7]. In order to test the e¡ect of di¡erent
detergents on NADH:NBQ oxidoreductase activity
of complex I in SMP, these compounds were added
as aqueous solutions before dilution of SMP. The
inhibition of the residual rate was assayed with
2 WM of NFQA or CC44 dissolved in ethanol which
was added after starting the catalytic reaction with
60 WM NBQ.
Detergent- and inhibitor-insensitive NADH:HAR
activity was measured using a Shimadzu UV-300
spectrophotometer in the dual wavelength mode by
following NADH oxidation at 340^400 nm (O= 6.10
mM31 cm31) at 30‡C [18].
2.4. E¡ect of detergents on binding of NFQA to
complex I in bovine submitochondrial particles
Fluorescence quench titrations were performed us-
ing the novel £uorescent complex I inhibitor NFQA
(excitation wavelength 316 nm and emission wave-
length 360 nm) at 25‡C as described previously [7].
Data were analyzed by ¢tting the following parame-
ter directly to the titration curve: speci¢c £uores-
cence of the bound and free inhibitor, Kd of
NFQA and the number of binding sites. Detergent
was added to the SMP solution before starting the
titration.
2.5. Kinetic model for concurrent competitive
inhibition by detergent and inhibitor
Assuming that some detergents act as competitive
complex I inhibitors the concurrent interaction of the
enzyme with the detergent and another competitive
inhibitor can be described in the framework of the
Michaelis^Menten theory by the following reaction
scheme:
1
with E, enzyme; D, detergent; I, inhibitor; Q, ubi-
quinone; QH2 ; ubiquinol, Kii, dissociation constant
for the inhibitor; Kdi, dissociation constant for the
detergent.
Then the catalytic rate is given by the following
equation:
v  VmaxUNBQ
KmU 1 IK ii 
D
Kdi
 
 NBQ
2
with Km, Michaelis^Menten constant for NBQ; v,
catalytic rate; Vmax, maximal catalytic rate.
The residual rate vi at a given concentration of
inhibitor [I] in the absence of detergent is given by:
vi  VmaxUNBQ
KmU 1 IK ii
 
 NBQ
3
It follows that the percentage IR by which this resid-
ual rate vi at a given concentration [I] is inhibited by
increasing concentrations of detergent [D] is :
IR  1003vviU100 4
Provided that all concentrations, Km for NBQ and
the I50 values for the inhibitor and the detergent are
known and the detergent and the inhibitor both act
as competitive inhibitors, these equations should al-
low simulation of the experimental data.
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For a given set of experimental conditions I50 val-
ues that are determined as the concentration of in-
hibitor or detergent required to reduce the NADH
oxidation rate to 50% of the uninhibited rate can be
converted to the corresponding dissociation con-
stants:
K ii  KmUI
inhibitor
50
NBQ3Km 5
and
Kdi  KmUI
detergent
50
NBQ3Km 6
2.6. Puri¢cation of bovine complex I
All preparation steps were performed at 4‡C. Bo-
vine heart mitochondria which were prepared ac-
cording to [19], were diluted in 50 mM Tris/HCl,
2 mM KCN, pH 7.4 to a protein concentration of
35 mg/ml (or 17.5 WM cytochrome aa3, cytochrome
aa3 content in mitochondrial membranes is 0.5 nmol/
mg). After adding Triton X-100 to a ¢nal concentra-
tion of 1.75% (20% stock solution; w/v) and NaCl to
a ¢nal concentration of 600 mM (4 M stock solution)
the suspension was stirred for 2 min and then cen-
trifuged for 60 min at 180 000Ug. The supernatant
contained matrix proteins, cytochrome c, most of
succinate dehydrogenase (complex II) and ATP syn-
thase (complex V). The pellet was resuspended in
300 mM sucrose, 2 mM EGTA, 10 mM K-phos-
phate, 10 mM Tris/HCl, pH 7.4, homogenized and
adjusted to a protein concentration of 40 mg/ml total
protein (or 30 WM cytochrome aa3, cytochrome aa3
content in pre-extracted membranes is 0.7 nmol/mg).
Then an equal volume of 4% Triton X-100, 1.2 M
NaCl, 300 mM sucrose, 20 mM Tris/HCl, pH 7.4
was added. After stirring for 2 min the extract was
centrifuged for 60 min at 180 000Ug. The red super-
natant contained most of cytochrome bc1 complex
(complex III) and NADH:ubiquinone oxidoreduc-
tase (complex I). The green pellet contained the cy-
tochrome c oxidase (complex IV). The red superna-
tant was adjusted to a ¢nal concentration of 50 mM
Na-phosphate (500 mM stock solution) and addi-
tional 1% Triton X-100. The extract was bound to
an equal volume of hydroxylapatite which was equil-
ibrated with 0.05% Triton X-100, 250 mM NaCl,
50 mM Na-phosphate, pH 7.4. For reducing the
salt concentration and further delipidation the hy-
droxylapatite column was washed with one volume
of 0.1% Triton X-100, 250 mM NaCl, 50 mM so-
dium phosphate, pH 7.4. Elution of complex I and
complex III occurred simultaneously at 200 mM
K-phosphate, 0.5% Triton X-100, pH 7.4. The frac-
tions containing complex I were pooled and diluted
with 0.1% Triton X-100, 20 mM Tris/HCl, pH 7.4 to
50 mM K-phosphate. This pool was applied to a
DEAE Biogel A (100^200 wet mesh; Bio-Rad Labo-
ratories) column equilibrated with 0.1% Triton
X-100, 50 mM NaCl, 20 mM Tris/HCl, pH 7.4.
For detergent exchange the bound protein was
washed with one column volume of 0.1% dodecyl-
maltoside, 50 mM NaCl, 20 mM Tris/HCl, pH 7.
Complex I eluted at 200 mM NaCl, 0.1% dodecyl-
maltoside, 20 mM Tris/HCl, pH 7.4. Under these
conditions the cytochrome bc1 complex remained
bound to the column as it required 280 mM NaCl
for elution. The resulting yellowish fractions were
pooled according to NADH:ubiquinone oxidoreduc-
tase activity. For further delipidation and elimination
of residual cytochrome c oxidase the Biogel A pool
was applied to a TSK G 4000 SW column (Toso-
Haas) and was eluted in 200 mM KCl, 0.1% dode-
cylmaltoside, 20 mM Tris/HCl, pH 7.4. The pool
containing pure complex I was concentrated by ul-
tra¢ltration through a YM-100 membrane (Amicon)
and was stored in liquid nitrogen.
2.7. Protein sequencing
For amino-terminal sequencing the subunits of iso-
lated complex were separated by tricine SDS^PAGE
[17]. After transfer onto a polyvinylidene-di£uoride
membrane individual subunits were sequenced by au-
tomated Edman degradation, in an Applied Biosys-
tems 473 A pulsed-liquid protein sequencer.
3. Results
3.1. E¡ects of detergents on inhibitor binding and
inhibition
The interaction of various detergents with complex
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I in bovine submitochondrial particles was analyzed.
Three di¡erent polyoxyethylene-ether detergents
(Triton X-100, Thesit, Brij-35), the sugar detergent
dodecylmaltoside and two di¡erent bile acid deriva-
tives (K-cholate, Chaps) were included in this study.
Within the group of polyoxyethylene-ethers Triton
X-100 and Thesit are known to be strongly delipidat-
ing while Brij-35 is not capable of extracting proteins
from a membrane.
In general, loss of NADH:NBQ oxidoreductase
activity and loss of sensitivity of the residual rate
towards NFQA inhibition caused by increasing de-
tergent concentrations were found to develop in par-
allel (Fig. 1). As a rule, higher concentrations of
detergents were needed to decrease inhibition of the
residual activity (Fig. 1, open circles) than for inhi-
bition of the catalytic rate (Fig. 1, ¢lled circles).
Although eventually all detergents abolished the cat-
alytic activity of complex I, a concentration of 0.01%
or less of the polyoxyethylene-ether detergents was
su⁄cient for 50% inhibition, but between 0.1 and
1% of dodecylmaltoside and the bile acid derivatives
was necessary to achieve the same e¡ect. Strikingly,
the polyoxyethylene-ethers, especially Triton X-100
and Thesit exert their e¡ect on complex I at concen-
trations below their CMC while on the other hand
dodecylmaltoside and Chaps decrease the catalytic
activity and inhibitor sensitivity only at concentra-
tions well above their CMC. For Brij-35 we observed
a signi¢cant loss of activity at low concentrations
and a complete insensitivity to NFQA already at
0.1% compared to 1% for dodecylmaltoside, while
the CMC for both detergents are quite similar. The
molar I50 value was 5.8 WM for Thesit and 150 WM
for Triton X-100. It should be noted that this I50
Fig. 1. E¡ect of detergents on inhibitor binding. NADH:NBQ
activity (b) was measured as described in Section 2 at pH 7.4
and 30‡C. Inhibition of the residual rate (a) was assayed by
the addition of 2 WM NFQA to the assay. Black arrows indi-
cate the loss of NFQA binding as determined by £uorescence
quench titration.
Fig. 2. Binding characteristics of NFQA. Submitochondrial par-
ticles from bovine heart were diluted in 1 mM EDTA, 1 mM
MgCl2, 75 mM Na-phosphate, pH 7.4 to a ¢nal complex I con-
centration of 0.15 mM [7]. NFQA (structure see insert) was
added from a 15 mM stock solution in ethanol. The excitation
maximum at 316 nm and the emission maximum at 360 nm
were used to follow NFQA binding. The £uorescence was
quenched by 92 þ 5% upon binding to complex I, the apparent
Kd was 2.4 þ 0.5 nM (n = 12).
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value for Triton X-100 is considerably higher than
the value reported by Ushakova et al. [20]. However,
when Kdi was calculated using Eq. 6 and thereby
taking into account the di¡erent experimental condi-
tions of the two studies the resulting values are
rather similar.
The e¡ect of the same detergents on equilibrium
binding of NFQA was studied by £uorescence
quench titration. NFQA (Fig. 2) is a £uorescent in-
hibitor that shows a marked quench of £uorescence
by 92 þ 5% upon binding to complex I (Fig. 2). In the
absence of detergents an apparent Kd of 2.4 þ 0.5 nM
(n = 12) was determined and one binding site per
complex I for NFQA was found by this method.
Compared to the related compound DQA [7] binding
of NFQA is tighter and its £uorescence is quenched
to a much greater extent. Therefore, it was better
suited for this study. In the presence of increasing
concentrations of detergents the £uorescence quench
of NFQA gradually disappeared indicating loss of
binding of the inhibitor to its binding site in complex
I. The black arrows in Fig. 1 indicate the approxi-
mate concentration of detergent up to which NFQA
binding could still be followed by this method. These
concentrations have to be considered only as esti-
mates and the experiment is performed at much high-
er concentrations of complex I than the kinetics.
Nevertheless, for all detergents tested the concentra-
tions were in the same range, above which signi¢cant
e¡ects on the inhibition of the residual catalytic ac-
tivity in the presence of a given concentration of the
detergent were observed (Fig. 1, open circles), and
above which equilibrium binding was lost. This in-
dicates that the detergent-induced loss of inhibition
was caused by impairment of inhibitor binding and
not by some structural change generating a bypass
route for electron transfer onto ubiquinone.
To further investigate the inhibitory mechanism of
the polyoxyethylene-ether detergents, we systemati-
cally varied the Triton X-100 to protein ratio and
measured the speci¢c NADH:NBQ oxidoreductase
activity of complex I (Fig. 3). The inhibitory e¡ect
was found to be strictly dependent on the absolute
detergent concentration and not a¡ected by the de-
tergent to protein ratio. This further excludes lipid
extraction as the cause for the inhibitory action of
Triton X-100.
Overall we concluded from these results that Tri-
ton X-100 and Thesit should be considered as spe-
ci¢c inhibitors of complex I. They seemed to interact
with complex I as single molecules and obviously
delipidation played no signi¢cant role at concentra-
tions where the detergents display their inhibitory
e¡ect. On the other hand, inhibition by dodecylmal-
toside, K-cholate and Chaps that was observed at
much higher concentrations was probably at least
partly due to more general detergent e¡ects like
phase partitioning and delipidation.
To test our conclusion that the polyoxyethylene
detergents behaved like other complex I inhibitors
we treated the experiments shown in Fig. 1C and E
as a situation where two inhibitors compete for the
same substrate binding site. The corresponding Mi-
chaelis^Menten type kinetic model is depicted in Eq.
1. This scheme is based on the assumption that the
inhibitor and the detergent exhibit competitive inhi-
bition. As only CC44 and other derivatives of Cap-
saicin show competitive inhibition [11], we measured
catalytic activity and degree of inhibition by CC44 in
the presence of increasing concentrations of Thesit.
The competing e¡ects are illustrated by the curves
shown in Fig. 4 that depict the extent of inhibition
of the residual rate in the presence of a ¢xed concen-
tration of CC44 by increasing amounts of Thesit.
Assuming concurrent binding of detergent and inhib-
itor according to Eq. 1 the data were ¢tted with Eq.
4 using independently determined, ¢xed values for
the Km of NBQ (2.2 WM), the dissociation constant
for Thesit Kdi (0.22 WM, calculated from I50 accord-
Fig. 3. E¡ect of Triton X-100 on NADH:ubiquinone oxidore-
ductase activity. NADH:NBQ activity was measured as a func-
tion of the concentrations of Triton X-100 and amount of SMP
in the cuvette.
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ing to Eq. 6) and 60 WM NBQ. For 1 and 2 WM
CC44 the best numerical ¢t shown in Fig. 4 gave
an I50 value for CC44 of 120 nM which is in good
agreement with directly obtained values [7]. Fig. 4
shows that the experimental data for 1 and 2 WM
CC44 were described very well by the kinetic model
of Eqs. 2^4. At higher CC44 concentrations (s 2
WM) the overall line shape remained unchanged
and the curve was shifted in the expected direction,
but obviously complex partitioning phenomena
started to cause some deviation from the kinetic
model (data not shown). If compounds exhibiting
non-competitive inhibition like rotenone and pierici-
din A were used in the same experiment, Eq. 4 could
not be applied. However, qualitatively comparable
results were observed re£ecting a more complex but
essentially similar situation for these inhibitors (data
not shown).
3.2. Puri¢cation of inhibitor-sensitive bovine
complex I
Our ¢ndings about the e¡ect of detergents on cat-
alytic activity, inhibition and inhibitor binding were
instrumental for the development of a novel large-
scale chromatographic preparation method for bo-
vine complex I. A summary of a typical preparation
is presented in Table 1.
The detergent Triton X-100 was found to be indis-
pensable for selective pre-extraction (0.5 g Triton
X-100/g total protein) of bovine heart mitochondria
which removes complexes II and V. For extraction of
complex I a Triton X-100 to protein ratio of 1 g/g
was used which leaves more than 98% of complex IV
in the membrane fraction. Apart from resulting in a
2^3-fold increase of speci¢c HAR activity (see Table
1), the hydroxylapatite column allowed e⁄cient deli-
pidation and reduction of the salt concentration,
thereby avoiding ammonium sulfate precipitation
steps common in other complex I preparations [2^4].
The key step to restore NADH:NBQ oxidoreduc-
tase activity and inhibitor sensitivity of complex I
was the exchange of detergent from Triton X-100
to dodecylmaltoside on the DEAE Biogel A column:
Table 1
Yield and purity of complex I during preparation
Preparation step/detergent Total protein (mg) Speci¢c activity (Wmol min31 mg31) Total units (%)
Membranes 7490 3.4 100
Pre-extraction sediment/Triton X-100 5100 5.1 102
Extraction supernatant/Triton X-100 2830 9.6 106
Hydroxylapatite pool/Triton X-100 670 24 63
Biogel A pool/dodecylmaltoside 230 45 40
TSK pool/dodecylmaltoside 48 49 9
The speci¢c activity was measured as electron-transfer rate from NADH (200 WM) to the arti¢cial electron acceptor HAR (2 mM) at
340 nm minus 400 nm (30‡C).
Fig. 4. Concurrent competition of Thesit and CC44 for the
NBQ binding site. The degree of inhibition of the residual
NADH:NBQ oxidoreductase activity of SMP by 1 WM (F) and
2 WM (b) CC44 in the presence of increasing concentrations of
the polyoxyethylene-ether detergent Thesit was measured. The
lines represent the least-square ¢t of Kii for CC44 based on Eq.
4. The following parameters were used to calculate both curves:
Km(NBQ) = 2.2 WM, [NBQ] = 60WM, Kii(CC44) = 4.7 nM and
Kdi(Thesit) = 0.22 WM (see Section 2 for details).
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While the pooled fractions from the hydroxylapatite
column in Triton X-100 exhibited only a very low
rate of ubiquinone reduction that was not a¡ected
by the addition of hydrophobic inhibitors (data not
shown), the eluate from the Biogel A column in do-
decylmaltoside exhibited a substantial recovery of
NADH:NBQ oxidoreductase activity that was fully
sensitive to DQA (Table 2).
The yield after this step was 40% as judged by
HAR activity compared to mitochondrial mem-
branes and complex I was 80^90% pure (Table 1).
This is su⁄cient for most kinetic and spectroscopic
studies. The remaining contaminant was found to be
mostly cytochrome c oxidase. Assuming an average
molecular mass of 750 g/mol for the phospholipids in
the inner mitochondrial membrane [21], the phos-
pholipid content of complex I at this stage (Biogel
A pool) was W500 nmol/mg and ubiquinone content
was about 0.1 nmol/mg (Table 2).
The ¢nal size exclusion chromatography with a
TSKgel G 4000 SW column removes most of the
residual cytochrome oxidase and polymers of com-
plex I. After this step the preparation contained
about 100 phospholipid molecules and 1.1 þ 0.1
FMN per mg of protein (Table 2). This is very close
to the value expected for pure enzyme based on a
total molecular mass of around 940 kDa. The ubi-
quinone content was below the detection level. Upon
re-chromatography on the same column complex I
elutes as a single and symmetric peak, indicating a
monodisperse state of the enzyme (data not shown).
The SDS^PAGE of subsequent preparation steps
shown in Fig. 5 illustrates that no signi¢cant contam-
ination remains after the TSKgel column. However,
optical spectra of the isolated enzyme still identi¢ed
cytochrome oxidase as a very minor contaminant of
1^2% of the total protein (data not shown) which is
about the same as in the preparation by Finel et al.
Fig. 5. Stages of complex I puri¢cation. Silver-stained tricine
SDS^PAGE of isolated complex I and di¡erent stages of prepa-
ration was performed according to [17]. The protein samples
(5 Wg total protein, see Table 1) were incubated for 30 min at
35‡C in 4% SDS (w/v), 2% mercaptoethanol, 10% glycerol,
0.01% Serva blue G, 50 mM Tris/HCl, pH 7.0. The numbers
indicate molecular masses. The six largest hydrophilic proteins
of complex I were identi¢ed by N-terminal sequencing. Lane A,
membranes; lane B, sediment of pre-extraction; lane C, super-
natant of extraction; lane D, hydroxylapatite pool; lane E, Bio-
gel A pool; lane F, TSK pool. See also Table 1.
Table 2
Characterization of isolated complex I
Preparation step FMN
(nmol/mg)
Phospholipid
(nmol/mg)
Ubiquinone
(nmol/mg)
Speci¢c activity
(Wmol min31 mg31)
Inhibition
(%)
Biogel A pool 0.8 þ 0.1 (n = 3) W500 0.10 1.1 þ 0.1 (n = 3) s 90
TSK pool 1.1 þ 0.1 (n = 3) W100 not detectable 0.45 þ 0.05 (n = 3) s 90
FMN, phospholipid and ubiquinone contents were determined as described in Section 2. The speci¢c activity was measured at pH 7.4
and 30‡C as electron-transfer rate from NADH (100 WM) to NBQ (60 WM) at 340 nm minus 400 nm. Inhibition was tested by adding
2 WM of DQA or piericidin A to the assay mixture (see Fig. 7).
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(see Fig. 4 in [4]). These same authors have observed
a loss of the 42 kDa subunit in their preparation
upon chromatography on a Mono Q column. To
exclude this inhomogeneity for our preparation we
have performed N-terminal sequencing of the band
in the SDS gel consisting of the 39 and 42 kDa sub-
units (see Fig. 5). The intensity of the PTH amino
acid peaks in the HPLC following Edman degrada-
tion suggested that nearly equal amounts of the two
subunits are present in the puri¢ed enzyme.
EPR spectra of the isolated enzyme at 12 K (Fig.
6A) show signals from four iron^sulfur centers (N1b,
N2, N3, N4) as reported for other less pure prepa-
rations of complex I [22]. At lower temperature (5 K)
and high microwave power the ¢fth FeS center N5
[22] was identi¢ed with gx;y;z 1.90, 1.93, 2.07 (data
not shown). N2 is known to be sensitive to deter-
gent-induced structural changes of complex I [4].
Therefore, we compared the lineshape of the gz sig-
nal of cluster N2 in isolated complex I and SMP
(Fig. 6B). There was neither a shift nor a line broad-
ening detectable in our puri¢ed enzyme.
Fig. 6. EPR spectra of puri¢ed complex I. A: EPR spectrum of puri¢ed complex I (12.7 mg/ml, TSK pool) reduced with 6.5 mM
NADH. The spectrum shows signals typical of the four FeS centers N1b, N2, N3, N4, denoted according to the nomenclature of
Ohnishi [22]. The corresponding g values (gx, gy, gz) were N1b: 1.92, 1.94, 2.02, N2: 1.93, 1.93, 2.05, N3: 1.86, 1.93, 2.04, N4: 1.89,
1.94, 2.11. B: Comparison of the linewidth of the gz signal of cluster N2 in isolated complex I (same sample as A) and SMP (protein
concentration, 21.4 mg/ml, reduced with 10 mM NADH). SMP from bovine heart mitochondria were prepared according to published
procedures [34,35] Both spectra were corrected for a baseline drift, mainly due to the gz signal of cluster N3. EPR conditions for A
and B: sample temperature, 12 K; microwave frequency, 9.48 GHz; microwave power 0.1 mW; modulation amplitude 0.64 mT.
Fig. 7. Instant inhibition of puri¢ed complex I. The complex I
(TSK pool) concentration in the assay mixture was 22 Wg/ml
corresponding to about 25 nM complex I. About 95% of the
catalytic activity was inhibited within a few seconds after addi-
tion of 2 WM piericidin A from an ethanolic stock solution dur-
ing the assay. No preincubation or addition of phospholipid
was needed.
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The NBQ reductase activity of isolated complex I
(Biogel A pool, cf. Table 2) was 1.1 Wmol min31
mg31 and could be increased to 2.2 Wmol min31
mg31 in the presence of 0.10 mg/ml egg yolk phos-
pholipid. This speci¢c activity is signi¢cantly higher
than comparable preparations of similar purity [2].
After further puri¢cation and delipidation the activ-
ity decreased to 0.45 Wmol min31 mg31 (TSK pool)
while inhibitor sensitivity of 95% was preserved (Fig.
7). It was not possible to increase this activity by
simply adding phospholipid to the assay mixture.
4. Discussion
Complex I is the largest and least understood mul-
tiprotein complex of the mitochondrial respiratory
chain. Its investigation has been severely hampered
in the past by the sensitivity to detergents during
enzyme puri¢cation evident in particular as a loss
of inhibitor sensitivity. This study analyzes the inter-
action of di¡erent detergents with complex I to de-
velop an isolation procedure for pure, monodisperse
and inhibitor-sensitive enzyme.
Our results demonstrate that in contrast to dode-
cylmaltoside and derivatives of bile acids, some poly-
oxyethylene-ether detergents are speci¢c inhibitors of
complex I. These compounds are of similar or even
higher potency as well known inhibitors like amytal
[23] or capsaicin [24]. The inhibitory action of these
detergents was found to be independent of their solu-
bilizing and delipidating properties. Inhibition of
complex I by Triton X-100 was reported earlier
[20,25,26], but the polyoxyethylene-ether detergent
Thesit studied here was found to be 25-fold more
e⁄cient than Triton X-100. In fact inhibitor potency
is obviously linked to the chain length of both the
alkyl- and the polyoxyethylene-ether moiety [27].
Binding analysis by £uorescence quench titration
[7] using the novel quinazoline type inhibitor NFQA
(cf. Fig. 2) revealed that the detergent-induced loss of
sensitivity of the residual activity to other potent in-
hibitors of complex I was in fact due to loss of bind-
ing and not caused by the creation of an electron
bypass to ubiquinone. We have shown that the loss
of inhibitor sensitivity of residual activity in the pres-
ence of detergent can be quantitatively described
(Fig. 4) by a simple Michaelis^Menten type kinetic
model assuming that the inhibitor CC44 and the de-
tergent Thesit act as competitive inhibitors for ubi-
quinone (see Eq. 1).
In summary, our study demonstrates that polyoxy-
ethylene-ether detergents act as speci¢c, competitive
complex I inhibitors. This seems to be a major cause
for the loss of activity and inhibitor sensitivity in
many complex I preparations. However, at higher
detergent concentrations additional e¡ects may be-
come important, as unspeci¢c delipidation or disinte-
gration of the complex.
These results prompted us to develop a novel pu-
ri¢cation procedure which yields bovine complex I in
active and inhibitor-sensitive state. Triton X-100 is
one of the best non-ionic, non-denaturing detergents
for di¡erential extraction of mitochondrial mem-
brane proteins [10]. On the other hand we had
learned that this detergent is unsuitable to isolate
complex I in an active and inhibitor-sensitive form
as it acts as a speci¢c inhibitor. However, this e¡ect
was reversible and complex I regained its full inhib-
itor sensitivity by exchanging the detergent from Tri-
ton X-100 to dodecylmaltoside after the ¢rst chro-
matographic step in our puri¢cation protocol. This
further supports the notion that Triton X-100 is a
reversible inhibitor of complex I.
The phospholipid content in puri¢ed complex I
was found to have a signi¢cant e¡ect on catalytic
activity, as the speci¢c activity of the preparation
on the level of the Biogel A pool could be doubled
by addition of external phospholipid. Furthermore
we observed a decrease of activity after extensive
delipidation (500C100 mol phospholipid/mg com-
plex I) on the TSKgel G 4000 SW column. In con-
trast to the preparation described in [4] even after
this extensive delipidation our puri¢ed enzyme was
fully sensitive to hydrophobic complex I inhibitors
and inhibition required no added phospholipid or
preincubation steps.
The puri¢ed enzyme was found to contain 1 mol
FMN/mol complex I. Thus, we found no evidence
for a doubling of the £avin-containing 51 kDa sub-
unit as has been proposed by Albracht and de Jong
[28]. Five di¡erent iron^sulfur clusters were identi¢ed
in the puri¢ed complex I by EPR spectroscopy. We
could not detect a shift or broadening of the gz line
of the cluster N2 signal caused by our puri¢cation
protocol. Therefore, we conclude that detergent and
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delipidation had no e¡ect on the environment of this
iron^sulfur center.
The preparation of pure and fully inhibitor-sensi-
tive complex I will prove useful for further studies of
this enzyme. However, while in the same range as
other comparable preparations, the turnover number
for ubiquinone reductase activity of the isolated com-
plex I in dodecylmaltoside was still less than 10%
when compared to submitochondrial particles. As
we excluded detergents and a general depletion of
phospholipids as reason for this loss of activity,
one has to consider more speci¢c factors to explain
this phenomenon. For example, it would be possible
that complex I needs a speci¢c type of phospholipid,
e.g. cardiolipin, for full activity. Another attractive
idea would be a loss of a tightly bound quinone in
the course of the puri¢cation procedure. Prosthetic
quinones have been proposed as a component of
several hypothetical mechanistic schemes for com-
plex I [29^33]. It is therefore tempting to speculate
that the low ubiquinone content of our preparation
might explain the low speci¢c activity. Ubiquinone
reconstitution experiments with the isolated enzyme
will be needed to test this hypothesis.
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